Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s) [Phase 1]

View source ↗

Summary

This is a Phase 1 study evaluating the safety, tolerability, pharmacokinetics and preliminary clinical activity of RO7673396 in participants with advanced solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• RO7673396 (RO7673396)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: RECRUITING